dc.contributor.author | van den Brand, Annick D. | |
dc.contributor.author | Bajard, Lola | |
dc.contributor.author | Steffensen, Inger-Lise Karin | |
dc.contributor.author | Brantsæter, Anne Lise | |
dc.contributor.author | Dirven, Hubert | |
dc.contributor.author | Louisse, Jochem | |
dc.contributor.author | Peijnenburg, Ad | |
dc.contributor.author | Ndaw, Sophie | |
dc.contributor.author | Mantovani, Alberto | |
dc.contributor.author | De Santis, Barbara | |
dc.contributor.author | Mengelers, Marcel J. B. | |
dc.date.accessioned | 2022-06-10T06:30:58Z | |
dc.date.available | 2022-06-10T06:30:58Z | |
dc.date.created | 2022-06-01T11:10:55Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Toxins. 2022, 14 (4), 1-21. | |
dc.identifier.issn | 2072-6651 | |
dc.identifier.uri | https://hdl.handle.net/11250/2998213 | |
dc.language.iso | eng | |
dc.title | Providing Biological Plausibility for Exposure-Health Relationships for the Mycotoxins Deoxynivalenol (DON) and Fumonisin B1 (FB1) in Humans Using the AOP Framework | |
dc.title.alternative | Providing Biological Plausibility for Exposure-Health Relationships for the Mycotoxins Deoxynivalenol (DON) and Fumonisin B1 (FB1) in Humans Using the AOP Framework | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 1-21 | |
dc.source.volume | 14 | |
dc.source.journal | Toxins | |
dc.source.issue | 4 | |
dc.identifier.doi | 10.3390/toxins14040279 | |
dc.identifier.cristin | 2028681 | |
dc.relation.project | EC/H2020/733032 HBM4EU | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |